Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 2.8B | 3.3B | 2.9B | 2.8B |
Cost of revenue | 714M | 1.0B | 790M | 737M |
Gross profit | 2.1B | 2.3B | 2.2B | 2.0B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 789M | 830M | 795M | 740M |
Operating income | 800M | 953M | 864M | 814M |
Non operating interest income | ||||
Income | 10M | 12M | 15M | 17M |
Expense | 369M | 370M | 368M | 355M |
Other income expense | 95M | 79M | 33M | 85M |
Pretax income | 536M | 674M | 544M | 561M |
Tax provision | 92M | 116M | 93M | 83M |
Net income | 444M | 558M | 451M | 478M |
Basic EPS | — | 1 | — | 0.9 |
Diluted EPS | — | 1 | — | 0.9 |
Basic average shares | — | 500.3M | — | 496.2M |
Diluted average shares | — | 500.6M | — | 496.4M |
EBITDA | 1.4B | 1.5B | 1.5B | 1.3B |
Net income from continuing op. | 444M | 558M | 451M | 478M |
Minority interests | -40M | -38M | -36M | -39M |
Preferred stock dividends | — | — | — | — |